This article provides a regulatory perspective on some of the technical challenges that growing cannabis markets face, specifically focusing on product standardization, quality control testing, and consumer education and awareness amid a rapidly developing industry.
Recently reintroduced to Congress, the bipartisan Protect Infant Formula From Contamination Act aims to strengthen FDA’s oversight of infant formula manufacturers by expanding certain authorities, allowing the agency to better ensure the safety and resiliency of the country’s infant formula supply.
A recent report published by the U.S. Government Accountability Office (GAO) highlighted the complex and fragmented oversight of the U.S. food supply, concluding that a national food safety strategy could help ensure federal agencies are working together to more successfully reduce foodborne illnesses.
Reintroduced to U.S. Congress on February 3, the Expanded Food Safety Investigation Act seeks to grant FDA the authority to collect microbial samples from concentrated animal feeding operations, also referred to as “factory farms,” during foodborne illness outbreak investigations.
This episode of Food Safety Five covers the U.S. Food and Drug Administration’s (FDA’s) recent ban on red dye 3, including the legal and scientific justifications for the decision, as well as external pressures from various parties leading to the ban.
The Tucson Environmental Justice Task Force has sued FDA for failing to act on a petition urging the agency to set limits for per- and polyfluoroalkyl substances (PFAS) in foods.
In this episode of Food Safety Matters, we speak to Lucy Angarita of GS1 US about the challenges of, and progress made toward, compliance with FSMA 204 as the January 2026 compliance date approaches. Lucy also discusses actionable steps for companies to advance their traceability journeys.
Sara Brenner, M.D., M.P.H., a longtime FDA and federal government employee, has been appointed Acting Commissioner of the agency. She will lead the agency until the Senate confirms President Trump’s nomination for FDA Commissioner.
The Trump Administration has ordered U.S. public health agencies, such as CDC and FDA, to temporarily pause external communications, including scientific reports and health advisories, until further notice. Any messaging leaving an HHS agency must be approved by a presidential appointee.
RSS
